Association between foldability and aggregation propensity in small disulfide-rich proteins

Antioxidants and Redox Signaling

Volumn 21, Issue 3, 2014, Pages 368-383

  Fraga, Hugo ^a   Graña Montes, Ricardo ^a   Illa, Ricard ^a   Covaleda, Giovanni ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISULFIDE; DISULFIDE RICH PROTEIN; GLOBULAR PROTEIN; HEAT SHOCK PROTEIN 70; INTRINSICALLY DISORDERED PROTEIN; PROTEIN; UNCLASSIFIED DRUG; PROTEIN AGGREGATE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; BINDING SITE; DISULFIDE BOND; LIGHT SCATTERING; MUTATION; OXIDATION; PREDICTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN UNFOLDING; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN TERTIARY STRUCTURE;

DISULFIDES; OXIDATION-REDUCTION; PROTEIN AGGREGATES; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84903794008     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5543     Document Type: Article

References (82)

1. Anfinsen CB, Haber E, Sela M, and White FHJ. The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proc Natl Acad Sci U S A 47: 1309-1314, 1961.
2. Arias-Moreno X, Arolas JL, Aviles FX, Sancho J, and Ventura S. Scrambled isomers as key intermediates in the oxidative folding of ligand binding module 5 of the low density lipoprotein receptor. J Biol Chem 283: 13627-13637, 2008.
3. Arolas JL, Aviles FX, Chang JY, and Ventura S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem Sci 31: 292-301, 2006.
4. Arolas JL, Bronsoms S, Aviles FX, Ventura S, and Sommerhoff CP. Oxidative folding of leech-derived tryptase inhibitor via native disulfide-bonded intermediates. Antioxid Redox Signal 10: 77-85, 2008.
5. Arolas JL, Bronsoms S, Lorenzo J, Aviles FX, Chang JY, and Ventura S. Role of kinetic intermediates in the folding of leech carboxypeptidase inhibitor. J Biol Chem 279: 37261-37270, 2004.
6. Arolas JL, Bronsoms S, Ventura S, Aviles FX, and Calvete JJ. Characterizing the tick carboxypeptidase inhibitor: molecular basis for its two-domain nature. J Biol Chem 281: 22906-22916, 2006.
7. Arolas JL, Castillo V, Bronsoms S, Aviles FX, and Ventura S. Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function. J Mol Biol 392: 529-546, 2009.
8. Arolas JL, Lorenzo J, Rovira A, Vendrell J, Aviles FX, and Ventura S. Secondary binding site of the potato carboxypeptidase inhibitor. Contribution to its structure, folding, and biological properties. Biochemistry 43: 7973-7982, 2004.
9. Arolas JL and Ventura S. Protease inhibitors as models for the study of oxidative folding. Antioxid Redox Signal 14: 97-112, 2011.
10. Aslund F and Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell 96: 751-753, 1999.
11. Belli M, Ramazzotti M, and Chiti F. Prediction of amyloid aggregation in vivo. EMBO Rep 12: 657-663, 2011.
12. Bulaj G and Goldenberg DP. Phi-values for BPTI folding intermediates and implications for transition state analysis. Nat Struct Biol 8: 326-330, 2001.
13. Calloni G, Zoffoli S, Stefani M, Dobson CM, and Chiti F. Investigating the effects of mutations on protein aggregation in the cell. J Biol Chem 280: 10607-10613, 2005.
14. Castillo V, Grana-Montes R, Sabate R, and Ventura S. Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Biotechnol J 6: 674-685, 2011.
15. Chandonia JM, Hon G, Walker NS, Lo Conte L, Koehl P, Levitt M, and Brenner SE. The ASTRAL Compendium in 2004. Nucleic Acids Res 32: D189-D192, 2004.
16. Chandonia JM, Walker NS, Lo Conte L, Koehl P, Levitt M, and Brenner SE. ASTRAL compendium enhancements. Nucleic Acids Res 30: 260-263, 2002.
17. Chang JY. The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI. Biochemistry 35: 11702-11709, 1996.
18. Chang JY. A two-stage mechanism for the reductive unfolding of disulfide-containing proteins. J Biol Chem 272: 69-75, 1997.
19. Chang JY. Evidence for the underlying cause of diversity of the disulfide folding pathway. Biochemistry 43: 4522-4529, 2004.
20. Chang JY. Diversity of folding pathways and folding models of disulfide proteins. Antioxid Redox Signal 10: 171-177, 2008.
21. Chang JY and Li L. Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide: compartmentalization of folding intermediates and identification of kinetic traps. Arch Biochem Biophys 437: 85-95, 2005.
22. Chang JY, Schindler P, and Chatrenet B. The disulfide structures of scrambled hirudins. J Biol Chem 270: 11992-11997, 1995.
23. Chatrenet B and Chang JY. The disulfide folding pathway of hirudin elucidated by stop/go folding experiments. J Biol Chem 268: 20988-20996, 1993.
24. Cheek S, Krishna SS, and Grishin NV. Structural classification of small, disulfide-rich protein domains. J Mol Biol 359: 215-237, 2006.
25. Chiti F and Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366, 2006.
26. Chiti F, Stefani M, Taddei N, Ramponi G, and Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808, 2003.
27. Conchillo-Solé O, de Groot NS, Avilés FX, Vendrell J, Daura X, and Ventura S. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8: 65, 2007.
28. Covaleda G, del Rivero MA, Chavez MA, Aviles FX, and Reverter D. Crystal structure of novel metallocarboxypeptidase inhibitor from marine mollusk Nerita versicolor in complex with human carboxypeptidase A4. J Biol Chem 287: 9250-9258, 2012.
29. Creighton TE. Intermediates in the refolding of reduced ribonuclease A. J Mol Biol 129: 411-431, 1979.
30. Creighton TE. Protein folding coupled to disulphide bond formation. Biol Chem 378: 731-744, 1997.
31. Creighton TE, Hillson DA, and Freedman RB. Catalysis by protein-disulphide isomerase of the unfolding and refolding of proteins with disulphide bonds. J Mol Biol 142: 43-62, 1980.
32. de Groot N, Pallares I, Aviles F, Vendrell J, and Ventura S. Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct Biol 5: 18, 2005.
33. de Groot NS, Castillo V, Grana-Montes R, and Ventura S. AGGRESCAN: method, application, and perspectives for drug design. Methods Mol Biol 819: 199-220, 2012.
34. de Groot NS and Ventura S. Protein aggregation profile of the bacterial cytosol. PLoS One 5: e9383, 2010.
35. Denoncin K and Collet JF. Disulfide bond formation in the bacterial periplasm: major achievements and challenges ahead. Antioxid Redox Signal 19: 63-71, 2013.
36. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS, Reeves R, Kang C, Kissinger CR, Bailey RW, Griswold MD, Chiu W, Garner EC, and Obradovic Z. Intrinsically disordered protein. J Mol Graph Model 19: 26-59, 2001.
37. Espargaro A, Castillo V, de Groot NS, and Ventura S. The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case. J Mol Biol 378: 1116-1131, 2008.
38. Fersht AR. The sixth Datta Lecture. Protein folding and stability: the pathway of folding of barnase. FEBS Lett 325: 5-16, 1993.
39. Fischer M, Horn S, Belkacemi A, Kojer K, Petrungaro C, Habich M, Ali M, Kuttner V, Bien M, Kauff F, Dengjel J, Herrmann JM, and Riemer J. Protein import and oxidative folding in the mitochondrial intermembrane space of intact mammalian cells. Mol Biol Cell 24: 2160-2170, 2013.
40. Frand AR, Cuozzo JW, and Kaiser CA. Pathways for protein disulphide bond formation. Trends Cell Biol 10: 203-210, 2000.
41. Fuller E, Green BR, Catlin P, Buczek O, Nielsen JS, Olivera BM, Bulaj G. Oxidative folding of conotoxins sharing an identical disulfide bridging framework. FEBS J 272: 1727-1738, 2005.
42. Galzitskaya OV, Garbuzynskiy SO, and Lobanov MY. FoldUnfold: web server for the prediction of disordered regions in protein chain. Bioinformatics 22: 2948-2949, 2006.
43. Grana-Montes R, de Groot NS, Castillo V, Sancho J, Velazquez-Campoy A, and Ventura S. Contribution of disulfide bonds to stability, folding and amyloid fibril formation: the PI3-SH3 domain case. Antioxid Redox Signal 16: 1-15, 2012.
44. Guerois R, Nielsen JE, and Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 320: 369-387, 2002.
45. Guijarro JI, Sunde M, Jones JA, Campbell ID, and Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci U S A 95: 4224-4228, 1998.
46. Guo ZY, Qiao ZS, and Feng YM. The in vitro oxidative folding of the insulin superfamily. Antioxid Redox Signal 10: 127-139, 2008.
47. Hegyi H and Tompa P. Intrinsically disordered proteins display no preference for chaperone binding in vivo. PLoS Comput Biol 4: e1000017, 2008.
48. Hogg PJ. Disulfide bonds as switches for protein function. Trends Biochem Sci 28: 210-214, 2003.
49. Ivanova MI, Thompson MJ, and Eisenberg D. A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments. Proc Natl Acad Sci U S A 103: 4079-4082, 2006.
50. Jamroz M, Kolinski A, and Kmiecik S. CABS-flex: server for fast simulation of protein structure fluctuations. Nucleic Acids Res 41: W427-W431, 2013.
51. Jansens A, van Duijn E, and Braakman I. Coordinated nonvectorial folding in a newly synthesized multidomain protein. Science 298: 2401-2403, 2002.
52. Kallberg Y, Gustafsson M, Persson B, Thyberg J, and Johansson J. Prediction of amyloid fibril-forming proteins. J Biol Chem 276: 12945-12950, 2001.
53. Li YJ, Rothwarf DM, and Scheraga HA. Mechanism of reductive protein unfolding. Nat Struct Biol 2: 489-494, 1995.
54. Linding R, Schymkowitz J, Rousseau F, Diella F, and Serrano L. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342: 345-353, 2004.
55. Lindorff-Larsen K, Piana S, Dror RO, and Shaw DE. How fast-folding proteins fold. Science 334: 517-520, 2011.
56. Lobanov MY, Suvorina MY, Dovidchenko NV, Sokolovskiy IV, Surin AK, and Galzitskaya OV. A novel web server predicts amino acid residue protection against hydrogen-deuterium exchange. Bioinformatics 29: 1375-1381, 2013.
57. Luo X, Jiang Q, Song G, Liu YL, Xu ZG, and Guo ZY. Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin. FEBS J 279: 3166-3175, 2012.
58. Mamathambika BS and Bardwell JC. Disulfide-linked protein folding pathways. Annu Rev Cell Dev Biol 24: 211-235, 2008.
59. Marino SM and Gladyshev VN. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Mol Biol 404: 902-916, 2010.
60. Maurer-Stroh S. Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, Reumers J, Morris KL, Copland A, Serpell L, Serrano L, Schymkowitz JW, and Rousseau F Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods 7: 237-242.
61. Monsellier E and Chiti F. Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep 8: 737-742, 2007.
62. Mossuto MF, Bolognesi B, Guixer B, Dhulesia A, Agostini F, Kumita JR, Tartaglia GG, Dumoulin M, Dobson CM, and Salvatella X. Disulfide bonds reduce the toxicity of the amyloid fibrils formed by an extracellular protein. Angew Chem Int Ed Engl 50: 7048-7051, 2011.
63. Mu Y, Nordenskiold L, and Tam JP. Folding, misfolding, and amyloid protofibril formation of WW domain FBP28. Biophys J 90: 3983-3992, 2006.
64. Neklesa TK and Crews CM. Chemical biology: greasy tags for protein removal. Nature 487: 308-309, 2012.
65. Pace CN, Grimsley GR, Thomson JA, and Barnett BJ. Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. J Biol Chem 263: 11820-11825, 1988.
66. Pantoja-Uceda D, Arolas JL, Aviles FX, Santoro J, Ventura S, and Sommerhoff CP. Deciphering the structural basis that guides the oxidative folding of leech-derived tryptase inhibitor. J Biol Chem 284: 35612-35620, 2009.
67. Polticelli F, Raybaudi-Massilia G, and Ascenzi P. Structural determinants of mini-protein stability. Biochem Mol Biol Educ 29: 16-20, 2001.
68. Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckmann JS, Silman I, and Sussman JL. FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21: 3435-3438, 2005.
69. Rezaei-Ghaleh N, Blackledge M, and Zweckstetter M. Intrinsically disordered proteins: from sequence and conformational properties toward drug discovery. Chembiochem 13: 930-950, 2012.
70. Rousseau F, Schymkowitz J, and Serrano L. Protein aggregation and amyloidosis: confusion of the kinds. Curr Opin Struct Biol 16: 118-126, 2006.
71. Safavi-Hemami H, Gorasia DG, Steiner AM, Williamson NA, Karas JA, Gajewiak J, Olivera BM, Bulaj G, and Purcell AW. Modulation of conotoxin structure and function is achieved through a multienzyme complex in the venom glands of cone snails. J Biol Chem 287: 34288-34303, 2012.
72. Salinas G, Pellizza L, Margenat M, Flo M, and Fernandez C. Tuned Escherichia coli as a host for the expression of disulfide-rich proteins. Biotechnol J 6: 686-699, 2011.
73. Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, and Serrano L. The FoldX web server: an online force field. Nucleic Acids Res 33: W382-W388, 2005.
74. Sickmeier M, Hamilton JA, LeGall T, Vacic V, Cortese MS, Tantos A, Szabo B, Tompa P, Chen J, Uversky VN, Obradovic Z, and Dunker AK. DisProt: the Database of Disordered Proteins. Nucleic Acids Res 35: D786-D793, 2007.
75. Siekierska A, De Baets G, Reumers J, Gallardo R, Rudyak S, Broersen K, Couceiro J, Van Durme J, Schymkowitz J, and Rousseau F. a-Galactosidase aggregation is a determinant of pharmacological chaperone efficacy on Fabry disease mutants. J Biol Chem 287: 28386-28397, 2012.
76. Tzotzos S and Doig AJ. Amyloidogenic sequences in native protein structures. Protein Sci 19: 327-348, 2010.
77. Uversky VN, Gillespie JR, and Fink AL. Why are "natively unfolded" proteins unstructured under physiologic conditions. Proteins 41: 415-427, 2000.
78. Van Durme J, Maurer-Stroh S, Gallardo R, Wilkinson H, Rousseau F, and Schymkowitz J. Accurate prediction of DnaK-peptide binding via homology modelling and experimental data. PLoS Comput Biol 5: e1000475, 2009.
79. Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson CM, Aviles FX, and Serrano L. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A 101: 7258-7263, 2004.
80. Wedemeyer WJ, Welker E, Narayan M, and Scheraga HA. Disulfide bonds and protein folding. Biochemistry 39: 4207-4216, 2000.
81. Weissman JS and Kim PS. Reexamination of the folding of BPTI: predominance of native intermediates. Science 253: 1386-1393, 1991.
82. Yang ZR, Thomson R, McNeil P, and Esnouf RM. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 21: 3369-3376, 2005. i de Recerca